Optimizing Lung Cancer Treatment in HIV Infected Persons

Lung cancer is now a leading cause of death in HIV infected persons. Lung cancer survival is worse in HIV infected persons, in part due to uncertainty regarding the optimal treatment pathways for this group. In this project we will use data from several large, representative HIV cohorts to calibrate a well-validated, biologically-based simulation model of lung cancer (the Lung Cancer Policy Model) to determine the lung cancer treatments that offer the best life expectancy and quality-of-life for HIV infected lung cancer patients.

0